ScholarGate
Assistent

Sammenlign metoder

Gennemgå dine valgte metoder side om side; rækker, der afviger, er fremhævet.

Maskinlærings-augmenteret Difference-in-Differences (ML-DiD)×Propensity Score Matching×
FagområdeKausal inferensForskningsstatistik
FamilieRegression modelProcess / pipeline
Oprindelsesår2018-20201983
OphavspersonChernozhukov et al. (double/debiased ML framework); Sant'Anna & Zhao (2020) for DR-DiDPaul Rosenbaum and Donald Rubin
TypeCausal inference / semiparametricMethod
Oprindelig kildeChernozhukov, V., Chetverikov, D., Demirer, M., Duflo, E., Hansen, C., Newey, W., & Robins, J. (2018). Double/debiased machine learning for treatment and structural parameters. The Econometrics Journal, 21(1), C1-C68. DOI ↗Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗
AliasserML-DiD, double/debiased ML DiD, DML difference-in-differences, augmented DiDPSM, propensity score weighting, covariate balance
Relaterede63
ResuméMachine learning-augmented DiD combines the classic difference-in-differences identification strategy with flexible ML estimators for nuisance functions — the propensity score and the outcome regression — to obtain valid causal estimates even when treatment selection and outcome dynamics are complex, high-dimensional, or nonlinear. The approach, rooted in double/debiased machine learning (Chernozhukov et al., 2018) and doubly-robust DiD (Sant'Anna & Zhao, 2020), guards against misspecification bias while preserving the core DiD logic of before-after, treated-versus-control comparisons.Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias.
ScholarGateDatasæt
  1. v1
  2. 2 Kilder
  3. PUBLISHED
  1. v1
  2. 3 Kilder
  3. PUBLISHED

Gå til søgning Hent slides

ScholarGateSammenlign metoder: Machine learning-augmented difference-in-differences · Propensity Score Matching. Hentet 2026-06-15 fra https://scholargate.app/da/compare